Cerus Corp
NASDAQ:CERS
Cerus Corp
NASDAQ:CERS
Price:
2.41
USD
1.26%
Market Closed
Market Cap:
$462.9m
Relative Value
The Relative Value of one
CERS
stock under the Base Case scenario is
1.73
USD.
Compared to the current market price of 2.41 USD,
Cerus Corp
is
Overvalued by 28%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CERS
Relative Value
Base Case
1.73
USD
Overvaluation 28%
Multiples Across Competitors
CERS Competitors Multiples
Cerus Corp Competitors
Cerus Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Cerus Corp
NASDAQ:CERS
|
462.8m USD | 2 | -29 | -53.3 | -45.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
65.7B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.8T JPY | 10.7 | 39.1 | 28.4 | 34.1 | |
| CH |
|
Alcon AG
SIX:ALC
|
32B CHF | 4.1 | 39.5 | 16.4 | 32 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
108.9B DKK | 3.9 | 27.5 | 14.2 | 17 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD | 3.4 | 33 | 17.6 | 22.8 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP | 3 | 32.2 | 14.2 | 23.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.6B USD | 1.3 | -18.2 | 18.4 | 59.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
41.1B CNY | 9 | 24.9 | 22.5 | 22.5 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
865B JPY | 6.7 | 48.9 | 23.1 | 31.4 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5B USD | 3.3 | 29.9 | 12.7 | 15 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
